相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic investigations of unexplained acute hepatitis in children
Sofia Morfopoulou et al.
NATURE (2023)
Adeno-associated virus 2 infection in children with non-A-E hepatitis
Antonia Ho et al.
NATURE (2023)
AAV2 and severe acute hepatitis of unknown aetiology
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)
Evading and overcoming AAV neutralization in gene therapy
Joseph Earley et al.
TRENDS IN BIOTECHNOLOGY (2022)
Intrabiliary infusion of naked DNA vectors targets periportal hepatocytes in mice
Sereina Deplazes et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
A retrograde approach for liver gene transfer
Nicola Brunetti-Pierri et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
Liver Gene Therapy
Amit C. C. Nathwani et al.
HUMAN GENE THERAPY (2022)
AAV vectors: The Rubik's cube of human gene therapy
Amaury Pupo et al.
MOLECULAR THERAPY (2022)
Three-Country Snapshot of Ornithine Transcarbamylase Deficiency
Berna Seker Yilmaz et al.
LIFE-BASEL (2022)
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
Corinne J. J. Smith et al.
FRONTIERS IN IMMUNOLOGY (2022)
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression
Barbara A. Konkle et al.
BLOOD (2021)
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes
Mihaela Zabulica et al.
MOLECULAR THERAPY (2021)
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells
Giang N. Nguyen et al.
NATURE BIOTECHNOLOGY (2021)
Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector
Giulia De Sabbata et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series
Deepa H. Chand et al.
JOURNAL OF PEDIATRICS (2021)
Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan
Jun Kido et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
The burden of pharmacological treatment on health-related quality of life in people with a urea cycle disorder: a qualitative study
Gillian Yeowell et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2021)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Engineering adeno-associated virus vectors for gene therapy
Chengwen Li et al.
NATURE REVIEWS GENETICS (2020)
A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
Lili Wang et al.
SCIENCE ADVANCES (2020)
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Fathema Uddin et al.
FRONTIERS IN ONCOLOGY (2020)
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Lindsey A. George et al.
MOLECULAR THERAPY (2020)
Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
Deyun Lu et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes
Samantha L. Ginn et al.
JHEP REPORTS (2020)
Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort
Dany P. Perocheau et al.
HUMAN GENE THERAPY (2019)
Urea cycle disorders-update
Shirou Matsumoto et al.
JOURNAL OF HUMAN GENETICS (2019)
Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision
Johannes Haberle et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders
Jochen Meyburg et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Mary G. Prieve et al.
MOLECULAR THERAPY (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice
Lili Wang et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
Ding An et al.
CELL REPORTS (2017)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
Effects of Self-Complementarity, Codon Optimization, Transgene, and Dose on Liver Transduction with AAV8
Peter Bell et al.
HUMAN GENE THERAPY METHODS (2016)
Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update
Ljubica Caldovic et al.
JOURNAL OF GENETICS AND GENOMICS (2015)
Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias
Meng Li et al.
LIVER TRANSPLANTATION (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients
Anais Brassier et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Urea cycle disorders: A case report of a successful treatment with liver transplant and a literature review
Francesco Giuseppe Foschi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Xiao-Hui Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Promoter less gene targeting without nucleases ameliorates haemophilia B in mice
A. Barzel et al.
NATURE (2015)
Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Balaji Balakrishnan et al.
CURRENT GENE THERAPY (2014)
Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler-Najjar Syndrome
Giulia Bortolussi et al.
HUMAN GENE THERAPY (2014)
Significant Hepatic Involvement in Patients with Ornithine Transcarbamylase Deficiency
Renata C. Gallagher et al.
JOURNAL OF PEDIATRICS (2014)
A longitudinal study of urea cycle disorders
Mark L. Batshaw et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Pediatric Liver Transplantation for Urea Cycle Disorders and Organic Acidemias: United Network for Organ Sharing Data for 2002-2012
Emily R. Perito et al.
LIVER TRANSPLANTATION (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
AAV-encoded OTC activity persisting to adulthood following delivery to newborn spfash mice is insufficient to prevent shRNA-induced hyperammonaemia
S. C. Cunningham et al.
GENE THERAPY (2013)
Vector Sequences Are Not Detected in Tumor Tissue from Research Subjects with Ornithine Transcarbamylase Deficiency Who Previously Received Adenovirus Gene Transfer
Li Zhong et al.
HUMAN GENE THERAPY (2013)
Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectors
L. Wang et al.
GENE THERAPY (2012)
Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency
James M. Wilson et al.
MOLECULAR GENETICS AND METABOLISM (2012)
rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault
Paul N. Valdmanis et al.
MOLECULAR THERAPY (2012)
AAV Vectors Containing rDNA Homology Display Increased Chromosomal Integration and Transgene Persistence
Zhongya Wang et al.
MOLECULAR THERAPY (2012)
Induction and Prevention of Severe Hyperammonemia in the spfash Mouse Model of Ornithine Transcarbamylase Deficiency Using shRNA and rAAV-mediated Gene Delivery
Sharon C. Cunningham et al.
MOLECULAR THERAPY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Innate immune responses to AAV vectors
Geoffrey L. Rogers et al.
FRONTIERS IN MICROBIOLOGY (2011)
Early orthotopic liver transplantation in urea cycle defects: Follow up of a developmental outcome study
Philippe M. Campeau et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium
Jennifer Seminara et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Long-term outcome following pediatric liver transplantation for metabolic disorders
Terrell Stevenson et al.
PEDIATRIC TRANSPLANTATION (2010)
Adenoviruses: update on structure and function
W. C. Russell
JOURNAL OF GENERAL VIROLOGY (2009)
Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency
C. Cavicchi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
AAV2/8-mediated Correction of OTC Deficiency Is Robust in Adult but Not Neonatal Spfash Mice
Sharon C. Cunningham et al.
MOLECULAR THERAPY (2009)
Hereditary urea cycle diseases in Finland
Paivi Keskinen et al.
ACTA PAEDIATRICA (2008)
Phenotypic correction of ornithine transcarbamylase deficiency using tow dose helper-dependent adenoviral vectors
Nicola Brunetti-Pierri et al.
JOURNAL OF GENE MEDICINE (2008)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy
Nicola Brunetti-Pierri et al.
MOLECULAR THERAPY (2007)
Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors
David Moscioni et al.
MOLECULAR THERAPY (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
No evidence for tumorigenesis of AAV vectors in a large-scale study in mice
P Bell et al.
MOLECULAR THERAPY (2005)
The role of liver transplantation in urea cycle disorders
JV Leonard et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Long-term correction of ornithine Transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus
A Mian et al.
MOLECULAR THERAPY (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Liver transplantation in neonates
SS Sundaram et al.
LIVER TRANSPLANTATION (2003)
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine Transcarbamylase deficiency
SE Raper et al.
HUMAN GENE THERAPY (2002)
Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey
C Dionisi-Vici et al.
JOURNAL OF PEDIATRICS (2002)
Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts
B Rapp et al.
EUROPEAN JOURNAL OF PEDIATRICS (2001)
分享论文
